• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The relationship between central lymph node metastasis and the distance from tumor to thyroid capsule in papillary thyroid microcarcinoma without capsule invasion.无包膜侵犯的甲状腺微小乳头状癌中央淋巴结转移与肿瘤至甲状腺被膜距离的关系
Gland Surg. 2020 Jun;9(3):727-736. doi: 10.21037/gs-20-478.
2
[Analysis of risk factors for central lymph node metastasis in papillary thyroid microcarcinoma].[甲状腺微小乳头状癌中央区淋巴结转移的危险因素分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jan 7;54(1):12-17. doi: 10.3760/cma.j.issn.1673-0860.2019.01.004.
3
A Nomogram Based on Clinicopathological and Ultrasound Imaging Characteristics for Predicting Cervical Lymph Node Metastasis in cN0 Unilateral Papillary Thyroid Microcarcinoma.基于临床病理及超声影像特征的列线图预测cN0期单侧甲状腺微小乳头状癌颈部淋巴结转移
Front Surg. 2021 Dec 3;8:742328. doi: 10.3389/fsurg.2021.742328. eCollection 2021.
4
Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy.接受甲状腺全切术的临床N0期乳头状甲状腺癌患者发生大容量中央淋巴结转移的预测因素
Front Oncol. 2021 May 19;11:574774. doi: 10.3389/fonc.2021.574774. eCollection 2021.
5
Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.cN0 期甲状腺微小乳头状癌高容量中央区淋巴结转移的临床及超声危险因素:一项回顾性研究与Meta分析
Clin Endocrinol (Oxf). 2023 Apr;98(4):609-621. doi: 10.1111/cen.14834. Epub 2022 Nov 3.
6
Risk Factor Analysis for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌中央区淋巴结转移的危险因素分析
Int J Gen Med. 2021 Dec 16;14:9923-9929. doi: 10.2147/IJGM.S346143. eCollection 2021.
7
Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.临床淋巴结阴性甲状腺微小乳头状癌患者中央淋巴结转移危险因素的识别及预防性中央区颈淋巴结清扫对分期迁移和风险分层影响的评估
Bull Cancer. 2017 Jun;104(6):516-523. doi: 10.1016/j.bulcan.2017.03.005. Epub 2017 May 2.
8
An ultrasound-based nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma.一种基于超声的列线图用于预测甲状腺微小乳头状癌中央淋巴结转移
Med Ultrason. 2024 Dec 19;26(4):369-375. doi: 10.11152/mu-4411. Epub 2024 Jul 29.
9
Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas.临床因素、传统超声及超声造影特征相结合在不同大小甲状腺乳头状癌中央区淋巴结转移术前预测中的价值
Cancer Manag Res. 2021 Apr 19;13:3403-3415. doi: 10.2147/CMAR.S299157. eCollection 2021.
10
Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma.预测甲状腺微小乳头状癌中央区淋巴结转移的危险因素。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6199-205. eCollection 2014.

引用本文的文献

1
Thermal ablation for papillary thyroid microcarcinoma in the isthmus: a systematic review and meta-analysis.峡部甲状腺微小乳头状癌的热消融:一项系统评价和荟萃分析
Endocr Connect. 2025 Jul 24;14(7). doi: 10.1530/EC-25-0268. Print 2025 Jul 1.
2
Prediction model construction of cervical central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis utilizing conventional ultrasound and elastography.利用传统超声和弹性成像构建合并桥本甲状腺炎的乳头状甲状腺癌颈部中央淋巴结转移预测模型
Gland Surg. 2024 Dec 31;13(12):2325-2334. doi: 10.21037/gs-24-271. Epub 2024 Dec 27.
3
Thyroid Cancer Central Lymph Node Metastasis Risk Stratification Based on Homogeneous Positioning Deep Learning.基于均匀定位深度学习的甲状腺癌中央淋巴结转移风险分层
Research (Wash D C). 2024 Aug 20;7:0432. doi: 10.34133/research.0432. eCollection 2024.
4
Prognostication of papillary thyroid microcarcinoma based on preoperative ultrasound.基于术前超声的甲状腺微小乳头状癌的预测。
Front Endocrinol (Lausanne). 2023 Jan 30;14:1101705. doi: 10.3389/fendo.2023.1101705. eCollection 2023.
5
Nomograms Based on Serum -glycome for Diagnosis of Papillary Thyroid Microcarcinoma and Prediction of Lymph Node Metastasis.基于血清糖组学的列线图诊断甲状腺微小乳头状癌及预测淋巴结转移
Curr Oncol. 2022 Aug 23;29(9):6018-6034. doi: 10.3390/curroncol29090474.
6
Research Review of Thermal Ablation in the Treatment of Papillary Thyroid Carcinoma.甲状腺乳头状癌热消融治疗的研究综述
Front Oncol. 2022 Jul 1;12:859396. doi: 10.3389/fonc.2022.859396. eCollection 2022.
7
Ultrasonic Characteristics Improve Prediction of Central Lymph Node Metastasis in cN0 Unifocal Papillary Thyroid Cancer.超声特征可提高 cN0 单发甲状腺乳头状癌中央区淋巴结转移的预测。
Front Endocrinol (Lausanne). 2022 Jun 20;13:870813. doi: 10.3389/fendo.2022.870813. eCollection 2022.
8
Web-Based Ultrasonic Nomogram Predicts Preoperative Central Lymph Node Metastasis of cN0 Papillary Thyroid Microcarcinoma.基于网络的超声列线图预测 cN0 期甲状腺微小乳头状癌的术前中央区淋巴结转移。
Front Endocrinol (Lausanne). 2021 Sep 7;12:734900. doi: 10.3389/fendo.2021.734900. eCollection 2021.
9
Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.构建并验证经典型甲状腺乳头状癌颈淋巴结转移预测列线图。
J Endocrinol Invest. 2021 Oct;44(10):2203-2211. doi: 10.1007/s40618-021-01524-5. Epub 2021 Feb 14.

本文引用的文献

1
Thyroid cancer staging and genomics.甲状腺癌分期与基因组学。
Ann Transl Med. 2019 Mar;7(Suppl 1):S49. doi: 10.21037/atm.2019.03.11.
2
Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers.分化型甲状腺癌诊断与管理中的当前争议及未来方向
Gland Surg. 2018 Oct;7(5):473-486. doi: 10.21037/gs.2017.09.08.
3
Sonographic Volumetric Assessment Is a More Accurate Measure Than Maximum Diameter Alone in Papillary Thyroid Cancer.在甲状腺乳头状癌中,超声容积评估比单纯最大径测量更准确。
J Endocr Soc. 2018 Oct 15;2(11):1284-1292. doi: 10.1210/js.2018-00233. eCollection 2018 Nov 1.
4
Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.CN0 期甲状腺微小乳头状癌中央区淋巴结转移的预测因素:对 1304 例病例的回顾性分析。
Asian J Surg. 2019 Apr;42(4):571-576. doi: 10.1016/j.asjsur.2018.08.013. Epub 2018 Oct 19.
5
RISK FACTORS FOR CENTRAL LYMPH NODE METASTASES IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.甲状腺微小乳头状癌中央区淋巴结转移的危险因素。
Endocr Pract. 2018 Dec;24(12):1057-1062. doi: 10.4158/EP-2018-0305. Epub 2018 Oct 5.
6
Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study.根据临床病理因素和甲状腺结节超声特征预测甲状腺微小乳头状癌中央淋巴结转移:一项病例对照研究
Cancer Manag Res. 2018 Sep 4;10:3237-3243. doi: 10.2147/CMAR.S169741. eCollection 2018.
7
Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.肿瘤与甲状腺被膜之间距离对临床淋巴结阴性甲状腺乳头状癌中央区淋巴结转移的指示意义。
PLoS One. 2018 Jul 17;13(7):e0200166. doi: 10.1371/journal.pone.0200166. eCollection 2018.
8
Sonographic features of papillary thyroid microcarcinoma predicting high-volume central neck lymph node metastasis.预测中央区颈部高容量淋巴结转移的甲状腺微小乳头状癌的超声特征
Surg Oncol. 2018 Jun;27(2):172-176. doi: 10.1016/j.suronc.2018.03.004. Epub 2018 Mar 27.
9
Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移危险因素的临床分析。
J Endocrinol Invest. 2019 Feb;42(2):227-236. doi: 10.1007/s40618-018-0908-y. Epub 2018 Jun 6.
10
A favorable tumor size to define papillary thyroid microcarcinoma: an analysis of 1176 consecutive cases.用于定义甲状腺微小乳头状癌的适宜肿瘤大小:1176例连续病例分析
Cancer Manag Res. 2018 Apr 27;10:899-906. doi: 10.2147/CMAR.S154135. eCollection 2018.

无包膜侵犯的甲状腺微小乳头状癌中央淋巴结转移与肿瘤至甲状腺被膜距离的关系

The relationship between central lymph node metastasis and the distance from tumor to thyroid capsule in papillary thyroid microcarcinoma without capsule invasion.

作者信息

Zhu Mengting, Zheng Weihui, Xiang Yangfeng, Gu Jialei, Wang Kejing, Shang Jinbiao

机构信息

The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.

Department of Head and Neck Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, China.

出版信息

Gland Surg. 2020 Jun;9(3):727-736. doi: 10.21037/gs-20-478.

DOI:10.21037/gs-20-478
PMID:32775263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7347803/
Abstract

BACKGROUND

This study aims to explore the predictive factors of central lymph node metastasis (CLNM) in patients with papillary thyroid microcarcinoma (PTMC) without capsule invasion.

METHODS

From January 2016 to October 2018, 1,622 patients with PTMC, who underwent surgical treatment at Zhejiang Cancer Hospital, were enrolled in the present study. A model of multivariate logistic regression was developed to find the variables that were independently associated with CLNM. The results were presented in the odds ratio (OR) with a 95% confidence interval (CI). The nomogram for predicting CLNM was developed based on the results of the multivariate logistic regression analysis. The distance (distance >0) from tumor to capsule is defined as the shortest distance from the tumor boundary to the capsule or trachea.

RESULTS

The multivariate logistic regression analysis indicated that age, gender, tumor maximum diameter, tumor mean diameter, and tumor volume were independently associated with CLNM. In the 692 cases without capsular invasion, the distance from the capsule was not correlated to the CLNM. The joint model, which included age, gender, tumor volume, and capsular invasion, were analyzed using the ROC curve. The cut-off point for the prediction of CLNM was defined as a value of 0.208. The area under the ROC curve was 0.687, the sensitivity was 65.4%, and the specificity was 63.3%.

CONCLUSIONS

Gender, age, maximum diameter, mean diameter, tumor volume, and capsular invasion were independently associated with the CLNM. When there was no capsular invasion, the distance between the tumor and capsule was not correlated to the CLNM, suggesting that considering whether the tumor is close to the capsule may not be necessary for low-risk PTMC.

摘要

背景

本研究旨在探讨无包膜侵犯的甲状腺微小乳头状癌(PTMC)患者中央淋巴结转移(CLNM)的预测因素。

方法

2016年1月至2018年10月,纳入在浙江省肿瘤医院接受手术治疗的1622例PTMC患者。建立多因素逻辑回归模型以找出与CLNM独立相关的变量。结果以比值比(OR)及95%置信区间(CI)呈现。基于多因素逻辑回归分析结果绘制预测CLNM的列线图。肿瘤至包膜的距离(距离>0)定义为肿瘤边界至包膜或气管的最短距离。

结果

多因素逻辑回归分析表明,年龄、性别、肿瘤最大直径、肿瘤平均直径和肿瘤体积与CLNM独立相关。在692例无包膜侵犯的病例中,至包膜的距离与CLNM无关。使用ROC曲线分析包括年龄、性别、肿瘤体积和包膜侵犯的联合模型。预测CLNM的截断点定义为0.208。ROC曲线下面积为0.687,灵敏度为65.4%,特异度为63.3%。

结论

性别、年龄、最大直径、平均直径、肿瘤体积和包膜侵犯与CLNM独立相关。当无包膜侵犯时,肿瘤与包膜之间的距离与CLNM无关,提示对于低风险PTMC可能无需考虑肿瘤是否靠近包膜。